Advanced Biomedical Technologies, Inc.
Advanced Biomedical Technologies, Inc.
Your view on ABMT
Overview
What the company does, where it operates, and who runs it.
About Advanced Biomedical Technologies, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Hui Wang
- Headquarters
- 200 Park Avenue, New York City, NY, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Hui Wang
- Headquarters
- 200 Park Avenue, New York City, NY, US
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices.
It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures.
The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Advanced Biomedical Technologies, Inc., and the rating behind it. ABMT last traded at $0.0002; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Advanced Biomedical Technologies, Inc.. Starting points for Advanced Biomedical Technologies, Inc.: EPS -$0.0073, beta 1.53 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Advanced Biomedical Technologies, Inc.. Advanced Biomedical Technologies, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Advanced Biomedical Technologies, Inc.. Trailing twelve-month EPS for Advanced Biomedical Technologies, Inc. stands at -$0.0073. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Advanced Biomedical Technologies, Inc.. Advanced Biomedical Technologies, Inc. has reported as a listed company since 2010. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Advanced Biomedical Technologies, Inc. valued side by side against its closest peers. Advanced Biomedical Technologies, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Advanced Biomedical Technologies, Inc., and how their positions are changing. At a $20,000 market value, institutional positions materially move Advanced Biomedical Technologies, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Advanced Biomedical Technologies, Inc. executives and directors. Shares of Advanced Biomedical Technologies, Inc. have traded between $0.0001 and $0.0006 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Advanced Biomedical Technologies, Inc.. Advanced Biomedical Technologies, Inc. is a $20,000 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Advanced Biomedical Technologies, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Advanced Biomedical Technologies, Inc.. Coverage tracks Advanced Biomedical Technologies, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.